Universidad de Chile
Records under this name other than the patents Universidad de Chile holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,618,904 | Promoter with an Enriched Cytosine-Guanine Dinucleotide Region, Vectors, Cellular Lines, Method for Producing Recombinant Protein Formerly held In force · High confidence | In force | High confidence | |
| US 11,400,166 | AAV/XBP1S-HA Virus, Gene Therapy Method and Use Thereof in the Optimisation and Improvement of Learning, Memory and Cognitive Capacities Lapsed on the fee record Ended Aug 2, 2026 · High confidence | Lapsed on the fee record | Ended Aug 2, 2026 | High confidence |
| US 11,261,472 | Peptide Sequence of a Guide Protein for the Production of a Peptide of Interest, an Expression Vector, a Host Cell, and a Method for the Production of a Peptide of Interest Lapsed on the fee record Ended Mar 1, 2026 · High confidence | Lapsed on the fee record | Ended Mar 1, 2026 | High confidence |
| US 11,181,523 | Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers Lapsed on the fee record Ended Nov 23, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 23, 2025 | USPTO record |
| US 9,664,930 | In situ polymerisation process for obtaining an electro-optical apparatus, said polymer and electro-optical apparatus; and uses thereof Lapsed on the fee record Ended May 30, 2025 · USPTO record | Lapsed on the fee record | Ended May 30, 2025 | USPTO record |
| US 9,511,120 | Use of the angiotensin-(1-9) peptide or derivatives thereof, use of vectors overexpressing the ACE2 enzyme that produces angiotensin-(1-9) for preparing medicaments useful for preventing, reverting, inhibiting and/or reducing hypertension and/or inducing vasodilation Lapsed on the fee record Ended Dec 6, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2024 | USPTO record |
| US 10,683,546 | Kit for predicting treatment with glucocorticoids and method comprising the same Lapsed on the fee record Ended Jun 16, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 16, 2024 | USPTO record |
| US 8,198,300 | Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound Lapsed on the fee record Ended Jun 12, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2024 | USPTO record |
| US 10,634,682 | Method for visualizing biomolecules, such as proteins or nucleic acids, with the unaided eye, without needing to use potentially toxic compounds, exposure to ultraviolet (UV) light or fluorescence Lapsed on the fee record Ended Apr 28, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 28, 2024 | USPTO record |
| US 10,548,565 | Manual, portable ultrasonography device, with centralized control and processing in the hardware and with display outputs, which operates in real time with a high image refresh rate Lapsed on the fee record Ended Feb 4, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2024 | USPTO record |